1 mg/mL naloxone hydrochloride injection USP, for intravenous, intramuscular and subcutaneous administration.
Available as follows:
2 mL single dose disposable prefilled syringes, in the MIN-I-JET® system with 21 G. x 11/2” needle. Shrink Wrapped Packages of 10.
NDC 76329-1469-1 Stock No. 1469 (contains no preservative)
2 mL single dose disposable Luer-JetTM Luer-Lock Prefilled Syringe. Shrink Wrapped Packages of 10.
NDC 76329-3369-1 Stock No. 3369 (contains no preservative)
Syringe Assembly Directions:
The MIN-I-JET® syringe with needle, illustrated below, is the basic unit upon which all the other syringe systems are built; slight adaptations and/ or additional auxiliary parts create the other syringe systems. Assembly directions remain essentially the same.
USE ASEPTIC TECHNIQUE
Do not assemble until ready to use.
Store at 25˚C (77˚F); excursions permitted to 15˚-30˚C (59˚-86˚F). [See USP Controlled Room Temperature.]
Protect from light.
Store in carton until contents have been used.
INTERNATIONAL MEDICATION SYSTEMS, LIMITEDSO. EL MONTE, CA 91733, U.S.A. REV. 11-13
An Amphastar Pharmaceuticals Company
© INTERNATIONAL MEDICATION SYSTEMS, LIMITED 2013
|NALOXONE HYDROCHLORIDE naloxone hydrochloride injection|
|Labeler — General Injectables & Vaccines, Inc (108250663)|
Revised: 11/2021 General Injectables & Vaccines, Inc
All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.